Myriad Genetics, Inc. (MYGN)

4.29 +0.20 (+4.89%) USD  |  NASDAQ  |  May 08, 16:00
4.285 0.00 (0.00%) After-Hours: 20:00
More

Myriad Genetics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MYGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Atossa Therapeutics, Inc. Upgrade
AVITA Medical, Inc. Upgrade